2007
DOI: 10.1021/op700181n
|View full text |Cite
|
Sign up to set email alerts
|

First Scale-Up: Problems and Resolutions on the Synthesis of WAY-253752, a Novel, Dual-Acting SSRI/5HT1A Antagonist

Abstract: An alternative synthesis of WAY-253752, 1, a novel, dual-acting SSRI/5HT 1A antagonist, was developed and used for the first scaleup. Initially, the target compound was synthesized as part of a diasteromeric mixture separated by chiral preparative HPLC. The new route was designed around intermediates suitable for chiral resolution, and its conditions were successfully determined.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
15
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(15 citation statements)
references
References 8 publications
(7 reference statements)
0
15
0
Order By: Relevance
“…Chiral tetrahydrocarbazoles have been recognized as important structural motifs in a diversity of natural products and pharmacological compounds (Figure ) . A number of asymmetric methodologies have been developed for the construction of this type of cyclic architectures .…”
mentioning
confidence: 99%
“…Chiral tetrahydrocarbazoles have been recognized as important structural motifs in a diversity of natural products and pharmacological compounds (Figure ) . A number of asymmetric methodologies have been developed for the construction of this type of cyclic architectures .…”
mentioning
confidence: 99%
“…5 b However, to the best of our knowledge, a cycloaddition mode which depends on the electronic nature of the substituent is unprecedented in asymmetric gold catalysis. As a part of our continual program in developing asymmetric gold-catalyzed cycloadditions, 9 we report the gold catalyzed enantioselective [2+2] and [4+2] cycloadditions of 3-styrylindoles with N -allenamides ( Scheme 1b ), furnishing synthetically valuable tetrahydrocarbazole 10 , 11 and 3-cyclobutylindole 12 , 13 scaffolds, respectively, which frequently appear in natural products and bioactive compounds ( Fig. 1 ).…”
Section: Introductionmentioning
confidence: 99%
“…[32] This architecture widely exists in various naturally occurring alkaloids and synthetic analogues of medicinal importance, [33] some of which can be potentially used as tumor-growth inhibitors and protein kinase C inhibitors. [34] Notably, trebenzomine analogue 7 can be easily synthesized in 54 % overall yield through an operationally simple three-step procedure from 2 h, [35] thus indicating that potentially medicinal candidates can be readily accessed from simple starting materials.…”
mentioning
confidence: 99%